German Biotech Stock News

E.ON (XTRA:EOAN) has drawn fresh attention after reporting full year 2025 earnings and proposing a higher dividend of €0.57 per share, a 4% increase, despite lower sales and net income. See our latest analysis for E.ON. The proposed dividend increase and the recent earnings release come after a strong run in E.ON’s shares, with a 90 day share price return of 21.11% and a 1 year total shareholder return of 60.64%. This suggests momentum has been building even as reported net income moved lower...

RWE (XTRA:RWE) has entered into an agreement with Proxima Fusion, the Max Planck Institute and the State of Bavaria to commercialize fusion energy in Europe. The partners plan to work toward building what they aim to be the world's first commercial stellarator fusion power plant. The alliance focuses on moving fusion technology from research settings into industrial scale deployment in Europe. RWE shares most recently traded at €53.34, with the stock up 13.7% year to date and 81.0% over the...

Allianz (XTRA:ALV) is in focus after reporting fourth quarter and full year 2025 earnings, proposing a higher dividend for 2025, issuing 2026 operating profit guidance, and confirming a new share buyback plan. See our latest analysis for Allianz. The latest earnings, higher proposed dividend and fresh €2.5b buyback come after a mixed period for the share price, with a 1 day share price return of 1.01% but a weaker 7 day move of 5.90% and a 30 day share price return of 5.33%. At the same time,...

SMA Solar Technology (XTRA:S92) is back in focus after reporting 2025 results that showed a 0.9% sales decline, sharply lower EBITDA tied to impairments and restructuring, and contrasting performances across its core segments. See our latest analysis for SMA Solar Technology. The earnings update landed alongside a sharp 9.7% 1 day share price return to €32.0. However, the 30 day share price return of 11.0% and the year to date share price return of 10.5% point to fading momentum after a...

Guidance highlights and why they matter for investors Knorr-Bremse (XTRA:KBX) has issued earnings guidance for 2026, stating that it expects revenues between €8,000 million and €8,300 million and an operating EBIT margin of around 14%, assuming stable macro and geopolitical conditions. For investors, this guidance provides a concrete reference point for comparing the current share price with management’s expectations for the business, particularly in light of Knorr-Bremse’s role in rail and...

MTU Aero Engines (XTRA:MTX) has put up another solid set of numbers, with Q3 2025 revenue at €2.1b and EPS of €4.63, sitting within a trailing twelve month picture of €8.5b in revenue and EPS of €16.61. Over the past few quarters, the company has seen revenue move between €1.7b and €2.1b per quarter, while quarterly EPS ranged from €2.40 to €5.39. This has fed into trailing net income of €897m and a 10.6% net margin. For investors, that margin profile is a key signal, as it frames how much of...

Redcare Pharmacy (XTRA:RDC) has put another quarter on the board with Q3 FY 2025 revenue of €719.2 million and a net loss of €7.2 million, as the business continues to balance top line scale with the cost of growth. Over the past few reported periods, revenue has moved from €560.7 million in Q2 2024 to €675.1 million in Q4 2024, then into the €709.2 million to €719.2 million range in the first three quarters of FY 2025, while EPS swung from a loss of €1.30 in Q4 2024 to a profit of €0.46 in...

Nemetschek (XTRA:NEM) has appointed Alok Sharma as managing director and vice president for India, drawing attention to how its stock reflects ambitions in a construction market where digital tools are gaining traction. See our latest analysis for Nemetschek. The latest appointment in India comes as momentum around Nemetschek’s share price has been mixed, with a 1-day share price return of 1.48% and 7-day share price return of 6.93%, contrasting with a 90-day share price return decline of...

Why Mercedes-Benz Group Stock Is Back in Focus Mercedes-Benz Group (XTRA:MBG) is back on investors’ radar after the company continued its share buyback in late February and Bank of America reported crossing the 3% voting rights threshold. Together, these moves highlight ongoing capital management decisions and shifts in the shareholder base, providing additional context if you are tracking the stock’s return profile and ownership structure. See our latest analysis for Mercedes-Benz...

Bilfinger (XTRA:GBF) has put solid top line and bottom line figures on the table, with Q3 2025 revenue of €1.4b and basic EPS of €1.48, alongside net income of €55m that keeps the year’s earnings run rate firmly in focus. The company has seen quarterly revenue move from €1.30b in Q2 2024 to €1.36b in Q4 2024 and then to €1.38b in Q3 2025. Basic EPS has ranged from €1.25 in Q2 2024 to €1.39 in Q4 2024 and €1.48 in Q3 2025, giving investors a clear view of recent trading momentum. With the...

Traton FY 2025 Q3 headline numbers set the tone Traton (XTRA:8TRA) has put fresh numbers on the table for FY 2025 Q3, reporting revenue of €10.4b and basic EPS of €0.65, with net income excluding extra items at €324m as investors weigh how the business is tracking through the year. The group has seen quarterly revenue move from €11.6b and EPS of €1.17 in FY 2024 Q2 to €12.2b and €1.49 in FY 2024 Q4, then to €10.6b and €0.93 in FY 2025 Q1 and €11.3b and €0.49 in FY 2025 Q2. This provides a...

How Symrise’s FY 2025 Results Landed Against Expectations Symrise (XTRA:SY1) has just put fresh numbers on the table, with first half FY 2025 revenue at €2.6b and basic EPS of €1.92. Trailing 12 month EPS sits at €3.63 on revenue of €5.0b and net income of €506.9m. The company has seen revenue move from €4.9b to about €5.0b over the past year on a trailing 12 month basis, with basic EPS stepping up from €2.81 to €3.63 and net income from €392.4m to €506.9m. Together, these figures provide a...

Why Lufthansa is suddenly back in focus Deutsche Lufthansa (XTRA:LHA) is back on many watchlists after Middle East tensions disrupted key air corridors, pushed fuel costs higher, and coincided with labor disputes and an earnings update scheduled for March 6, 2026. See our latest analysis for Deutsche Lufthansa. At a latest share price of €8.402, Deutsche Lufthansa has seen short term pressure, with a 7 day share price return of an 8.51% decline and a 30 day share price return of a 5.85%...

Recent performance snapshot for Bayerische Motoren Werke Bayerische Motoren Werke (XTRA:BMW) has drawn investor attention after recent share price moves, with the stock last closing at €82.86 and showing mixed returns over the past week, month and past 3 months. Over 1 year, the total return sits at 4.88%, while longer horizons show a 0.22% total return over 3 years and 36.31% over 5 years. This provides investors with several time frames to compare recent trading with past performance. See...

Wüstenrot & Württembergische (XTRA:WUW) has drawn investor attention after a series of dividend increases and renewed foreign capital interest, reinforcing its image as a conservative, diversified play across insurance, housing finance, and banking. See our latest analysis for Wüstenrot & Württembergische. At a latest share price of €16.16, Wüstenrot & Württembergische has paired a 90 day share price return of 14.12% with a 1 year total shareholder return of 31.64%. This suggests momentum has...

Beiersdorf (XTRA:BEI) has posted its latest FY 2025 numbers with first half revenue of €5.2b and basic EPS of €2.47, while trailing 12 month figures show revenue of €9.9b and EPS of €4.25. The company has seen revenue move from €4.7b and EPS of €1.48 in 2H 2024 to €5.2b and EPS of €2.47 in 1H 2025. Trailing net income on a 12 month basis stands at €939m, alongside a profit margin that sits slightly higher than the prior year. That mix of steady earnings growth and a modestly firmer margin...

If you are wondering whether adidas shares are starting to look interesting or still too expensive, you are not alone. Many investors are asking what the current price really reflects about the business. The stock closed at €141.80, with a 10.5% decline over 7 days, a 5.6% decline over 30 days, a 15.3% decline year to date, a 39.9% decline over 1 year and a 48.9% decline over 5 years. This naturally raises questions about how expectations and risk are being priced in. Recent coverage around...

Volkswagen (XTRA:VOW3) is back in the legal spotlight after two US dealerships filed a class-action lawsuit over Scout-brand electric vehicle sales, raising questions about dealer relationships and potential long-term implications for shareholders. See our latest analysis for Volkswagen. The latest legal challenge lands after a softer period for the shares, with a 1 day share price return of 1.30% at €94.8 contrasting with a year to date share price return of 10.94% and a 1 year total...

Deutsche Telekom (XTRA:DTE) has been in focus after unveiling two major network moves: an expanded Nokia collaboration on cloud based, AI native RAN, and a Starlink deal for satellite direct to device coverage across hard to reach European regions. See our latest analysis for Deutsche Telekom. Those network deals land at a time when Deutsche Telekom’s 1 month share price return of 15.8% and 3 month share price return of 19.9% point to building momentum, even though the 1 year total...

Munich Re (XTRA:MUV2) reports record net profit for full-year 2025, completing its Ambition 2025 plan. The company announces a 20% increase in its annual dividend to shareholders. Munich Re launches a new share buyback program of up to €2.25b. Munich Re, listed as XTRA:MUV2, is one of the largest global reinsurance groups, providing risk transfer solutions across property, casualty, life and health, and specialty lines. As the sector continues to respond to evolving risk patterns and...

Oncology data moves into focus for Bayer stock Bayer (XTRA:BAYN) has drawn fresh attention after presenting new prostate cancer data at ASCO GU 2026, including Phase III results for XOFIGO and early Phase I outcomes for its targeted alpha therapy 225Ac-PSMA-Trillium. The company reported a 24% reduction in risk of death when XOFIGO was combined with enzalutamide versus enzalutamide alone in men with metastatic castration resistant prostate cancer and bone metastases. Median overall survival...

Fresenius SE KGaA (XTRA:FRE) is back in focus after reporting fourth quarter 2025 results, proposing a €1.05 dividend per share and outlining board changes alongside management’s comments on geopolitical and supply chain pressures. See our latest analysis for Fresenius SE KGaA. Even with the earnings beat, higher proposed dividend and board changes, the share price has slipped over the past week, with a 7 day share price return of 4.27%. However, a 1 year total shareholder return of 25.23%...

BASF (XTRA:BAS) has been highlighted as a key player in the ammonium sulfate market. A recent industry report points to projected growth in ammonium sulfate demand across fertilizers, food processing, and emissions control. The company is positioned among top global suppliers, which may create additional opportunities for business expansion. BASF is a global chemicals group with exposure to agricultural inputs and industrial applications where ammonium sulfate plays an important role. The...

Wondering whether SAP at €165.48 is starting to look attractive or still expensive compared to its fundamentals? This article is designed to help you put a clear value range around the stock. The share price has had a mixed run, with a 0.2% decline over the last 7 days and a 3.0% decline over 30 days, while year to date it is down 18.1% and 35.5% lower over 1 year. It is still up 55.2% over 3 years and 69.5% over 5 years. Recent headlines around SAP have focused on broader sector sentiment,...